Primacy of the 3B Approach to Control Risk Factors for Cardiovascular Disease among Type 2 Diabetes

Linong Ji, Dayi Hu, Changyu Pan, Jianping Weng, Yong Huo, Changsheng Ma, Yiming Mu, Chuanming Hao, Qiuhe Ji, Xingwu Ran, Benli Su, Hanjing Zhuo, Keith A A Fox, Michael Weber, Danyi Zhang, CCMR Advisory BoardCCMR-3B STUDY Investigators

Research output: Contribution to journalArticlepeer-review

Abstract

Individually, diabetes mellitus, hypertension, and dyslipidemia have been shown to increase the risk of cardiovascular disease. While traditional management of Type 2 diabetes has focused mainly on glycemic control, robust evidence supports the integration of hypertension and dyslipidemia management to reduce the risk of cardiovascular disease. The primary objective of this study was to assess the level of control of blood glucose, blood pressure, and blood lipids (3Bs) among patients with type 2 diabetes. An additional objective was to investigate the impact of hospital type, physician specialty, treatment pattern, and patient profile on clinical outcomes.
Original languageEnglish
Pages (from-to)925.e11–925.e22
JournalAmerican Journal of Medicine
Volume126
Issue number10
DOIs
Publication statusPublished - 27 Jun 2013

Keywords

  • Cardiovascular risk factor
  • China
  • Dyslipidemia
  • Hyperglycemia
  • Hypertension
  • Type 2 diabetes

Fingerprint Dive into the research topics of 'Primacy of the 3B Approach to Control Risk Factors for Cardiovascular Disease among Type 2 Diabetes'. Together they form a unique fingerprint.

Cite this